CGN Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,288
| Closed | -$275K | – | 257 |
|
|
2023
Q3 | $275K | Sell |
8,288
-566
| -6% | -$18.8K | 0.04% | 226 |
|
|
2023
Q2 | $325K | Buy |
8,854
+192
| +2% | +$7.04K | 0.05% | 189 |
|
|
2023
Q1 | $353K | Sell |
8,662
-465
| -5% | -$19K | 0.06% | 181 |
|
|
2022
Q4 | $468K | Buy |
9,127
+474
| +5% | +$24.3K | 0.08% | 169 |
|
|
2022
Q3 | $379K | Buy |
8,653
+1,540
| +22% | +$67.5K | 0.1% | 182 |
|
|
2022
Q2 | $373K | Buy |
7,113
+55
| +0.8% | +$2.88K | 0.11% | 169 |
|
|
2022
Q1 | $365K | Buy |
7,058
+13
| +0.2% | +$672 | 0.09% | 171 |
|
|
2021
Q4 | $416K | Buy |
+7,045
| New | +$416K | 0.11% | 162 |
|